Axicabtagene ciloleucel,Cyclophosphamide,Fludarabine
gilead
['yescarta', 'gilead', '$gild']
gilead's kite's yescarta car t-cell therapy achieves significant os improvement for r/r lbcl treatment. data presented at asco 2023 and published in nejm. $gild #positive 
Real-time news analysis & sentiment scoring (+/-) for stocks
Powered by @streetbeat_com
From the creators of @uscongbuysnews
Disclosure: https://t.co/eNe8LEd7CU